These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7781403)
1. Dose-intensive therapy for small cell lung cancer. Elias AD Chest; 1995 Jun; 107(6 Suppl):261S-266S. PubMed ID: 7781403 [TBL] [Abstract][Full Text] [Related]
2. Dose-intensive therapy in small cell lung cancer. Elias A Chest; 1998 Jan; 113(1 Suppl):101S-106S. PubMed ID: 9438698 [TBL] [Abstract][Full Text] [Related]
3. Dose-intensive therapy in lung cancer. Elias A Cancer Chemother Pharmacol; 1997; 40 Suppl():S64-9. PubMed ID: 9272137 [TBL] [Abstract][Full Text] [Related]
4. Little to learn from phase II trials in small-cell lung cancer. Leyvraz S; Stupp R Ann Oncol; 1999 Sep; 10(9):1007-9. PubMed ID: 10572597 [No Abstract] [Full Text] [Related]
5. Dose intensive chemotherapy in small cell lung cancer. Wolf M Lung Cancer; 2001 Sep; 33 Suppl 1():S125-35. PubMed ID: 11576718 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of small cell lung cancer]. Negoro S Gan To Kagaku Ryoho; 2005 Jun; 32(6):777-82. PubMed ID: 15984515 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy dose intensity in small cell lung cancer. Souhami RL; De Elvira MC Lung Cancer; 1994 Mar; 10 Suppl 1():S175-85. PubMed ID: 8087508 [TBL] [Abstract][Full Text] [Related]
10. [Importance of the initial chemotherapy dose in the treatment of small cell lung carcinoma: therapeutic perspectives]. Le Chevalier T; Le Cesne A; Arriagada R Bull Cancer; 1995; 82 Suppl 1():24s-28s. PubMed ID: 7626850 [TBL] [Abstract][Full Text] [Related]
11. Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomized phase II trial in small-cell lung cancer patients. Woll PJ; Thatcher N; Lomax L; Hodgetts J; Lee SM; Burt PA; Stout R; Simms T; Davies R; Pettengell R J Clin Oncol; 2001 Feb; 19(3):712-9. PubMed ID: 11157022 [TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor in the treatment of small cell lung cancer. Wolf M; Klausmann M; Havemann K Semin Oncol; 1994 Dec; 21(6 Suppl 16):51-6. PubMed ID: 7801147 [No Abstract] [Full Text] [Related]
13. High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience. Ayash LJ; Elias A; Wheeler C; Tepler I; Schwartz G; Schnipper L; Frei E; Antman K J Hematother; 1993; 2(4):507-11. PubMed ID: 7916250 [TBL] [Abstract][Full Text] [Related]
14. [Recent issue in the treatment of small-cell lung cancer]. Ueoka H; Hiraki S Gan To Kagaku Ryoho; 1998 Sep; 25(11):1665-70. PubMed ID: 9757190 [TBL] [Abstract][Full Text] [Related]
15. Combined chemoradiation therapy for limited-stage small-cell lung cancer. Teng M; Choy H; Ettinger D Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):107-15. PubMed ID: 10550834 [TBL] [Abstract][Full Text] [Related]
16. Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: repopulation as a cause of treatment failure? Brade AM; Tannock IF J Clin Oncol; 2006 Mar; 24(7):1020-2. PubMed ID: 16505418 [No Abstract] [Full Text] [Related]
18. [Treatment for limited-stage small cell lung cancer (LD-SCLC)]. Takada M; Yana T; Fukuoka M Nihon Rinsho; 2002 May; 60 Suppl 5():471-9. PubMed ID: 12101717 [No Abstract] [Full Text] [Related]